The estimated Net Worth of Geoffrey Mackay is at least $2.42 Milione dollars as of 28 December 2022. Geoffrey Mackay owns over 45,999 units of AvroBio Inc stock worth over $263,217 and over the last 6 years Geoffrey sold AVRO stock worth over $2,159,108.
Sign up
Geoffrey Mackay AVRO stock SEC Form 4 insiders trading
Geoffrey has made over 6 trades of the AvroBio Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Geoffrey exercised 45,999 units of AVRO stock worth $41,859 on 28 December 2022.
The largest trade Geoffrey's ever made was exercising 142,013 units of AvroBio Inc stock on 23 December 2022 worth over $58,225. On average, Geoffrey trades about 28,186 units every 105 days since 2019. As of 28 December 2022 Geoffrey still owns at least 188,012 units of AvroBio Inc stock.
You can see the complete history of Geoffrey Mackay stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Geoffrey Mackay's mailing address?
Geoffrey's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.
Insiders trading at AvroBio Inc
Over the last 6 years, insiders at AvroBio Inc have traded over $3,066,308 worth of AvroBio Inc stock and bought 2,395,057 units worth $31,037,133 . The most active insiders traders include Braden Michael Leonard, Bruce Booth e Venture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of $206,675. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth $973,626.
What does AvroBio Inc do?
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
What does AvroBio Inc's logo look like?
Complete history of Geoffrey Mackay stock trades at AvroBio Inc
AvroBio Inc executives and stock owners
AvroBio Inc executives and other stock owners filed with the SEC include:
-
Birgitte Volck,
President - Research & Development -
Erik Ostrowski,
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer -
Geoff MacKay,
President, Chief Executive Officer, Director -
Steven Avruch,
Secretary, Chief Legal Officer -
Geoff MacKay BSc,
Co- Founder, Pres, CEO & Director -
Geoff MacKay,
Co- Founder, Pres, CEO & Director -
Erik Ostrowski M.B.A.,
CFO & Treasurer -
Steven N. Avruch J.D.,
Chief Legal Officer & Sec. -
Philip Vickers,
Independent Director -
Bruce Booth,
Independent Chairman of the Board -
Christopher Paige,
Independent Director -
Phillip Donenberg,
Independent Director -
Annalisa Jenkins,
Independent Director -
Ian Clark,
Independent Director -
Gail Farfel,
Director -
Kim Raineri,
Chief Manufacturing and Technology Officer -
Chris Brinzey,
IR Contact Officer -
Deanna Petersen,
Chief Business Officer -
Dr. Essra Ridha FFPM, M.D.,
Chief Medical Officer -
Andreas Kouri,
Sr. VP of Global Supply Chain & External Manufacturing -
Azadeh Golipour Ph.D.,
Chief Technology Officer -
Deanna M. Petersen MBA,
Chief Bus. Officer -
Dr. Christopher Mason FMEDSCI, FRCS, M.D., Ph.D.,
Chief Scientific Officer -
Dr. Christopher Mason FMEDSCI, M.D., Ph.D., FRCS,
Chief Scientific Officer -
Deanna M. Petersen M.B.A., MBA,
Chief Bus. Officer -
Georgette Verdin,
Chief HR Officer -
Monique Da Silva,
Sr. VP of Corp. Communications -
Dr. Christopher Mason,
Chief Scientific Officer -
Kim Raineri M.B.A.,
Chief Manufacturing & Technology Officer -
Matthew Arnold,
Head of Operations -
Jeffrey Medin Ph.D.,
Scientific Founder -
Venture Fund X, L.P.Atlas V...,
-
Lifesciences Iii, L.P.Claru...,
-
Scott Requadt,
Director -
Vi, Llcsv Life Sciences Fun...,
-
Katina Dorton,
Chief Financial Officer -
Nerissa Kreher,
Chief Medical Officer -
Venture Associates X, L.P. ...,
10% owner -
Lifesciences Iii, L.P.Claru...,
-
Diana Escolar,
Chief Medical Officer -
Christopher Mason,
Chief Scientific Officer -
Essra Ridha,
Chief Medical Officer -
Azadeh Golipour,
Chief Technology Officer -
Braden Michael Leonard,